Flucom

Quick links to important sections

Flucom

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flucom

What is Flucom? (Fluconazole)

Flucom is a trade name for a prescription-only medicine containing the active ingredient Fluconazole (INN). This drug is a synthetically manufactured antifungal agent, classified as a triazole derivative within the broader azole family. Flucom is used to combat infections caused by various types of pathogenic fungi, yeasts, and molds throughout the body.

Property Description
Active Ingredient Fluconazole
Form Tablet, Oral Suspension, Solution for Injection
Pharmacological Class Azole Antifungal / Triazole Derivative
Common Purpose Combating systemic and mucosal fungal infections
Origin Synthetic Compound

What Type of Medicine is Flucom? (Identity, Class, and Composition)

Flucom is an antifungal drug whose active component, Fluconazole, is a highly refined, synthetic chemical compound designed to be selective against fungal cells. Pharmacological studies support its effectiveness and safety profile for systemic use. Flucom is differentiated by its availability in specialized forms, including a palatable oral suspension often prioritized for pediatric patients or those who struggle with swallowing tablets.

As a triazole derivative, Fluconazole is chemically distinct from older antifungal classes, which contributes to its improved properties, such as high oral bioavailability (absorption). This high absorption is clinically recognized for ensuring the medicine reaches infected tissues effectively, whether administered orally or intravenously.


Action and Forms for Systemic Use

The drug is supplied in multiple systemic forms, including tablets, powder for preparing an oral suspension (liquid), and a sterile solution for injection for intravenous administration. Flucom operates primarily by acting as a selective inhibitor of the enzyme lanosterol 14-alpha-demethylase in fungal cells. This mechanism prevents the synthesis of ergosterol, which is vital for the structural integrity of the fungal cell membrane.

By disrupting this essential process, Fluconazole exerts a fungistatic effect—it halts the growth and reproduction of the fungal organisms, allowing the patient’s immune system to clear the contained infection. The conclusion drawn from this mechanism is that the medicine serves to suppress the proliferation of fungi, offering a targeted defense against the causative agents of infection across different patient needs and administration settings.

Regulatory References

  1. NIH, Fluconazole Analogs and Derivatives
  2. NCBI Bookshelf, Fluconazole - StatPearls

What side effects are possible with Flucom?

Possible Side Effects and Safety Information

The safety profile of Flucom (fluconazole) is characterized by adverse reactions officially documented and classified by frequency and affected body system in regulatory prescribing information. According to this official data, the adverse reactions are categorized from very common to rare.

Very Common and Common Side Effects

Adverse reactions classified as Very Common (occurring in 10% or more of patients) primarily include headache. Effects listed as Common (occurring in 1% to less than 10% of patients) involve the Gastrointestinal System, typically manifesting as nausea, vomiting, diarrhea, and abdominal pain. Elevated liver function tests (ALT, AST) are also commonly documented, reflecting effects on the Hepatobiliary System, along with rash affecting the Skin and Subcutaneous Tissue.

Serious Adverse Reactions and Constraints

The official labeling highlights rare but clinically significant events that affect the safety profile. These Serious Adverse Reactions include severe hepatotoxicity, hepatic failure, and severe cutaneous reactions, such as Stevens-Johnson syndrome and Toxic Epidermal Necrolysis. Serious events affecting the Cardiac System, such as QT prolongation and Torsade de Pointes, are also documented.

Specific safety considerations exist for special populations and contexts. Caution is required in patients with pre-existing hepatic impairment. Furthermore, official regulatory documents state that co-administration with certain other medicinal products known to prolong the QT interval is contraindicated due to the risk of dangerous cardiac events.

Overdose and Emergency Response

Flucom Overdose and when to seek help

Documented Overdose Manifestations Severe Outcomes and Systemic Risk
Overdose has been associated with severe behavioral disturbances, including hallucinations and paranoid behavior (such as extreme fearfulness or suspiciousness). The acute risk profile includes severe neurological events like seizures and critical cardiac effects such as QT prolongation and the associated life-threatening ventricular arrhythmia, Torsade de pointes.

A suspected overdose of Flucom is classified by regulators as a scenario requiring immediate medical attention. This action is mandated due to the potential for the documented severe, life-threatening effects on the Central Nervous System and Cardiovascular System, as detailed in the official prescribing information.

Management is restricted to symptomatic treatment and general supportive measures, as no specific antidote is known to reverse the medicine’s effects. Interventions officially described in regulatory documents include the consideration of gastric lavage if clinically appropriate. Regarding the removal of the medicine from the body, the substance is primarily cleared through renal excretion. A 3-hour session of hemodialysis is documented as an effective procedural step, capable of decreasing the circulating plasma concentration by approximately 50%. This approach to elimination is often required in severe exposure cases.

Therapeutic Uses of Flucom

Flucom (fluconazole) is an important medication applied across therapeutic domains where additional symptomatic support is needed for fungal and yeast infections. This medicine is commonly used to help with managing conditions presenting with symptoms of infection, including those that manifest as symptoms related to localized discomfort like vaginal, mouth, and throat candidiasis, as well as those presenting as systemic or localized discomfort in the esophagus, abdomen, or blood. The medicine also supports the management of serious conditions, such as cryptococcal meningitis, and may assist with preventing infections in patients with weakened immune systems who are undergoing medical treatment.


Quick Fact: Relevant for easing symptoms that become more disruptive during flare-ups


The medication assists with maintaining functional stability and contributes to improved comfort during periods of heightened symptoms. As one benefit is described, “The medicine provides supportive relief when symptoms interfere with routine activities.” This approach helps ease the overall symptom burden in clinical settings that involve acute or unstable symptom patterns.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Contraindicated Populations

Use of Flucom is contraindicated and must be strictly avoided for specific populations as defined in official regulatory documents. This includes patients with known hypersensitivity to fluconazole, any other azole antifungal medicine, or formulation components. It is also absolutely prohibited for patients receiving certain co-administered medicines that prolong the QT interval and are metabolized by the CYP3A4 enzyme (e.g., cisapride or astemizole). Furthermore, patients with specific rare hereditary disorders, such as certain types of galactose intolerance (for capsules/tablets) or fructose intolerance (for oral suspension), are ineligible due to product excipients.


Conditional Eligibility and Restrictions

Certain groups are eligible for use but require special, labeled conditions or caution. Patients with impaired renal function (Creatinine Clearance le 50 mL/min) are subject to a required labeled dose adjustment for multi-dose regimens. Use is directed with caution in individuals with pre-existing liver dysfunction or heart rhythm problems (e.g., arrhythmia). Regarding age, the medicine is approved for adults and for specific uses in children aged 6 months and older; however, use is not established for specific indications, such as vaginal candidiasis, in children under 16 years. High-dose or prolonged use in pregnancy is officially not recommended.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Flucom's official interaction profile is defined by its inhibitory effect on key metabolic enzymes. Flucom is documented as a potent inhibitor of Cytochrome P450 (CYP) enzymes 2C9, 2C19, and 3A4. This activity results in an increased plasma concentration and exposure (AUC) of many co-administered medicinal products that are metabolized by these pathways, including the immunosuppressants cyclosporin and tacrolimus.


The most stringent constraints involve Formal Contraindicated Combinations due to significant interaction risk. Co-administration is formally prohibited with several drugs, including Astemizole, Cisapride, Pimozide, Quinidine, and Erythromycin. This prohibition is necessary because Flucom significantly increases the levels of these medicines, raising the risk of severe cardiac events such as QTc interval prolongation. Other prohibited combinations include Terfenadine (at higher Flucom doses), Flibanserin, Lomitapide, and Lonafarnib.


Specific interactions alter drug exposure or pharmacodynamic effect. For example, co-administration with Warfarin may increase prothrombin time (INR), and co-administration with Sulphonylureas may prolong their half-life, creating a potential for a hypoglycaemic episode. Conversely, certain medicines, such as Rifampicin and Cimetidine, decrease the plasma concentration of Flucom itself, altering its overall systemic exposure. No mandatory timing-separation rules or formal food/alcohol interactions are explicitly stated in the official regulatory labeling.

Mechanism of Action

The Pharmacodynamic Mechanism of Flucom

Flucom's mechanism begins with the selective inhibition of the fungal enzyme lanosterol 14-alpha-demethylase (Erg11p). This enzyme is a critical component of the pathogen's unique ergosterol biosynthesis pathway. The drug targets this fungal biochemistry, allowing the enzyme to be inhibited at concentrations that do not significantly affect homologous human enzymes.

Blocking the enzyme's activity initiates a dual cellular consequence: a deficiency of essential ergosterol and the accumulation of toxic 14-alpha-methyl sterols in the cell membrane. This results in structural and functional compromise of the fungal cell membrane, leading to the fungistatic consequence where the pathogen's growth and reproduction are halted.

This mechanism is physiologically constrained when the pathogen develops biological counter-mechanisms, such as mutations in the target enzyme or activation of efflux pumps (transporters) that actively expel the drug, thereby reducing its ability to inhibit the target.

Dosage and Administration Information

How to Use Flucom (Fluconazole) — Administration Guidelines

This section outlines the usage instructions for fluconazole.

Administration and Dosage Forms

Fluconazole is approved for administration by two primary routes: Oral (PO), using tablets or reconstituted suspension, and Intravenous (IV), using a sterile solution for slow infusion. The dose is generally the same for both oral and IV administration, as the oral formulation is highly absorbed. The medication may be taken with or without food.

Standard Dosing Protocol and Frequency

For most systemic infections, a loading dose—often double the maintenance dose—is typically administered on Day 1 to rapidly achieve drug levels. Following the loading dose, the maintenance dose is taken once daily. Uncomplicated vaginal candidiasis is often treated with a single 150 mg oral dose.

Key Procedural and Population Requirements

Requirement Instruction Summary
IV Infusion Rate Must be administered slowly, typically not exceeding 200 mg/hour.
Oral Suspension Requires shaking well before use and must be measured using a calibrated device.
Renal Adjustment After the initial dose, the dose must be reduced by 50% for patients with a Creatinine Clearance leq 50 mL/min.
Missed Dose If a dose is missed, take it as soon as remembered unless close to the next scheduled dose, in which case the missed dose is skipped. Do not double the dose.

These standardized instructions define the method, frequency, and dose adjustments necessary for the use of fluconazole.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Flucom (Fluconazole)


Evidence for Use in Mucosal Candidiasis

Flucom was studied for its application in common fungal infections of mucous membranes, such as in the mouth, throat, and vagina. The research landscape primarily consists of short-term Randomized Controlled Trials (RCTs) and open-label trials that focused on conditions characterized by physical discomfort. These studies were evaluated in populations of adults and certain pediatric patients, including those with compromised immune systems. Researchers primarily examined two key outcomes: the clinical resolution of symptoms and the mycological status, which is the laboratory confirmation that the fungus was undetectable.

Studies report how symptoms evolved in the observed populations during the acute treatment phase. Findings from these trials describe patterns observed in the studies regarding the outcomes defined by the study protocols. Long-term outcomes and the durability of the reported status over extended periods are not fully established across all types of mucosal candidiasis. Limited information is available regarding the long-term risk of the infection returning (relapse).


Evidence for Use in Invasive and Systemic Candidiasis

The evidence base for Flucom's use in systemic infections, such as when the fungus is detected in the bloodstream (candidemia), includes Randomized Controlled Trials (RCTs) and comparative trials. This evidence was evaluated in settings involving high physiological strain or stress. Research examined key endpoints, including mortality rates recorded at specific time points, and the measurements of fungal detection status from the bloodstream.

Studies report how symptoms evolved in the observed populations of critically ill patients, non-neutropenic adults, and neonatal and pediatric patients. Inconsistency has been observed in reported findings for infections caused by certain Candida species that may be inherently less susceptible to the medicine. Long-term functional recovery and outcomes describing episodic or acute changes beyond the initial hospitalization period are not fully established.


What Is Still Uncertain About Flucom Research

The scientific literature identifies several areas where research is limited or where certainty remains low. Evidence quality varies across studies, particularly for less common uses like endemic mycoses, where sample sizes were modest and non-randomized designs are common. Data remain insufficient concerning the research focused on the characteristics of infections caused by certain species of Candida that are naturally less sensitive to fluconazole. Furthermore, comparative evidence is lacking for many long-term or chronic outcomes. Research does not determine whether an individual will respond similarly, as study results reflect the specific conditions under which they were conducted.

Key Studies & References Fluconazole Drug Information (MedlinePlus)

Frequently Asked Questions (FAQ)

Common questions about Flucom (FAQ)

Q: What is Flucom used for besides its main listed purpose?

Official product information describes that, in addition to treating active fungal infections, fluconazole is approved for a prophylactic role (prevention). This means it can be used to reduce the incidence of candidiasis (a type of fungal infection) in high-risk patients, such as those undergoing bone marrow transplantation who receive chemotherapy or radiation.

Q: How quickly does Flucom start working after you take it?

The time it takes to notice improvement varies based on the type and severity of the infection. For localized infections, symptoms may begin resolving within 24 hours. For more serious, systemic infections, the full therapeutic effect may take 1 to 2 weeks, though signs of improvement are generally expected in the first few days.

Q: What is the longest period someone can generally take Flucom?

The duration of treatment is highly dependent on the condition being treated and is determined by a healthcare provider. For example, official dosing protocols describe treatment periods that can range from at least 2 weeks for certain mucosal infections up to 10 to 12 weeks or longer for certain systemic infections like cryptococcal meningitis.

Q: Can Flucom cause problems with sleep?

Sleep issues are not commonly listed in the regulatory description of adverse reactions. However, official post-marketing reports have infrequently noted central nervous system (CNS) effects, including somnolence (drowsiness). These reports reflect effects observed in real-world use.

Q: Is it normal to feel a bit dizzy when first starting Flucom?

Yes, dizziness is a recognized adverse reaction to fluconazole listed in the official prescribing information. Official product information recommends avoiding driving or operating machinery until the patient knows how the medication affects them.

Q: What kind of common over-the-counter medications should I check for interactions with Flucom?

Official information indicates that fluconazole is known to inhibit certain liver enzymes (specifically CYP2C9, CYP2C19, and CYP3A4) that metabolize many other drugs, including certain over-the-counter products. Co-administration can increase the concentration of these products, meaning that a review of all concurrent medicines may be necessary.

Q: Why do official documents warn about taking Flucom with grapefruit juice?

The official product information for fluconazole does not list grapefruit juice as causing a formal interaction or affecting the drug's absorption. The medication can be taken with or without food, as described in the administration guidelines.

Q: Can Flucom be taken by older adults (seniors)?

Yes, fluconazole is approved for use across the adult population, including older adults. Dosage adjustments are typically required only if the patient has impaired kidney function (Creatinine Clearance le 50 mL/min), which is a common consideration in the senior population.

Q: Is there a generic version of Flucom available?

Yes. Flucom is a trade name for the active ingredient Fluconazole, which is a widely available generic human prescription drug. Generic versions containing the same active ingredient are marketed under various names globally.

Q: Can men and women take Flucom for the same conditions?

Yes. Fluconazole is approved for both men and women for the treatment of systemic fungal infections. The suitability of the medication depends on the specific fungal infection being treated and the official indication, not the patient's sex.

Q: Can Flucom affect blood sugar levels?

Official information indicates an indirect effect when fluconazole is taken with certain diabetes medicines. Fluconazole can increase the systemic exposure of sulfonylurea class drugs, which may prolong their action and create a risk of a hypoglycemic episode (abnormally low blood sugar).

Q: Does Flucom affect birth control pills?

Official documentation describes that fluconazole is not likely to affect the efficacy of most hormonal contraceptives. However, some studies have suggested a small chance that it could increase the levels of hormones in the body when taken with combined hormonal pills.

Q: Can I take pain relievers while I am on Flucom?

Fluconazole is a strong inhibitor of the enzyme CYP2C9. For certain pain relievers metabolized by this enzyme, such as celecoxib, the dose may need to be adjusted to prevent toxicity. Official product information highlights the importance of a healthcare provider being aware of all pain relievers, including non-prescription ones.

Q: Why is Flucom sometimes prescribed for people who seem healthy?

The drug is officially approved for a prophylactic role, which is the use of a medicine to prevent disease. This use is targeted at high-risk patient groups, such as those undergoing cancer therapy or bone marrow transplants, to reduce the chance of developing a serious fungal infection.

Q: Is it mandatory to finish the full course of Flucom even if I feel better?

Official patient information describes that the prescribed course of medication should be completed even if symptoms improve. If the full course is not completed, the infection may not be completely cleared and the symptoms may return.

Q: What is the difference between the capsule and tablet forms of Flucom?

Regulatory bioequivalence studies indicate that both the tablet and capsule forms of fluconazole have comparable absorption and systemic exposure in the body. The choice of form is often based on patient preference or availability.

Q: Does Flucom interact with common supplements like multivitamins or herbal products?

Specific drug interaction studies with general supplements or most herbal products have not been conducted. However, due to fluconazole's inhibitory effect on liver enzymes, official guidance emphasizes the importance of a healthcare provider being aware of all products being taken.

Q: Can Flucom cause mental or mood changes?

Official post-marketing experience reports have listed mood changes among the rare or unknown side effects. Additionally, mental changes, such as fearfulness or suspiciousness, may be symptoms of a potential overdose.

Q: Can I drive or operate machinery while taking Flucom?

Official regulatory information advises avoiding driving or operating machinery until it is known how the medication affects the patient. Fluconazole is documented to cause side effects such as dizziness or seizures.

Q: What should I do if I accidentally take two doses of Flucom close together?

In case of accidental overdose, even if no symptoms are present, official guidelines recommend contacting a doctor or poison control center immediately. Overdose symptoms may include fearfulness or mental changes.

Q: Does Flucom affect cholesterol levels?

Post-marketing reports of adverse events have rarely included increases in certain blood lipids such as cholesterol and triglycerides (hypercholesterolemia and hypertriglyceridemia).

Q: Is Flucom a controlled substance?

No. Fluconazole is a prescription drug that requires a prescription, but it is not classified as a scheduled controlled substance by the U.S. Drug Enforcement Administration (DEA).

Q: How long does Flucom stay in your system after the last dose?

According to the pharmacokinetics data, fluconazole has a plasma elimination half-life of approximately 30 hours. This means it takes about six days (five half-lives) for the active substance to be substantially cleared from the body.

Q: What is the expected outcome of treatment with Flucom?

The expected result of the treatment is to halt the growth and reproduction of the fungal organism. The drug works primarily by being fungistatic, which then allows the patient's immune system to clear the contained infection.

Q: Are there different brand names for the same medicine as Flucom?

Yes. Flucom is one of many trade names for the active ingredient Fluconazole. As the active ingredient is available in generic form, it is marketed under numerous different brand names across the world.

Q: What is the purpose of the 'inactive ingredients' in Flucom?

Inactive ingredients, also known as excipients, are added to the drug to serve several purposes. They help give the medicine its specific physical form (tablet, capsule), ensure stability over time, and help in the proper absorption and delivery of the active ingredient (Fluconazole) into the body.

Q: What should I do if I am traveling while taking Flucom?

Official storage guidelines must be followed to maintain drug integrity. The medicine must be stored at a controlled room temperature (typically below 30 C / 86 F), protected from moisture, and kept in the original container. Liquid forms must also be protected from freezing.

Q: Can Flucom cause problems with vision?

While uncommon, post-marketing reports of adverse events have included central nervous system side effects such as visual field defect. If vision problems occur, it is recommended to seek guidance from a healthcare provider.

How should Flucom be stored and disposed of?

Official Storage and Disposal Requirements

Fluconazole (Flucom) storage and handling requirements are based on official regulatory documentation to maintain product stability and safety. Dry forms, such as tablets and capsules, must be stored below 30 C (86 F) and protected from moisture. All forms must be kept in the tightly closed original container and out of the reach of children.

Handling and Stability:

Requirement Constraint
Freezing Must be protected from freezing (applies to liquid forms/IV solution).
In-Use Stability Reconstituted oral suspension must be discarded after 14 days (2 weeks).

Disposal:

Expired or unused Fluconazole must be disposed of safely. Do not flush the medication down the toilet or pour it down a drain unless specifically instructed by the labeling. Disposal should follow government guidelines, preferably utilizing a community drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Flucom found in:

A-Z Index: